These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 9236948)

  • 21. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cognitive subscale of the "Alzheimer's Disease Assessment Scale" in a Brazilian sample.
    Schultz RR; Siviero MO; Bertolucci PH
    Braz J Med Biol Res; 2001 Oct; 34(10):1295-302. PubMed ID: 11593304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive factors affecting free recall, cued recall, and recognition tasks in Alzheimer's disease.
    Yamagishi T; Sato T; Sato A; Imamura T
    Dement Geriatr Cogn Dis Extra; 2012 Jan; 2(1):278-85. PubMed ID: 22962551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease.
    Knox MR; Lacritz LH; Chandler MJ; Munro Cullum C
    Clin Neuropsychol; 2003 May; 17(2):216-9. PubMed ID: 13680428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The delayed word recall task using ADAS-Jcog word booklet effectively divides patients with mild cognitive impairment from normal elderly people.
    Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
    Nihon Ronen Igakkai Zasshi; 2007 Jul; 44(4):490-6. PubMed ID: 17827808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADCS Prevention Instrument Project: overview and initial results.
    Ferris SH; Aisen PS; Cummings J; Galasko D; Salmon DP; Schneider L; Sano M; Whitehouse PJ; Edland S; Thal LJ;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S109-23. PubMed ID: 17135805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
    Alva G; Isaacson R; Sadowsky C; Grossberg G; Meng X; Somogyi M
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):920-7. PubMed ID: 24549933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].
    Pákáski M; Drótos G; Janka Z; Kálmán J
    Orv Hetil; 2012 Mar; 153(12):461-6. PubMed ID: 22411219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
    Schneider LS; Olin JT; Doody RS; Clark CM; Morris JC; Reisberg B; Schmitt FA; Grundman M; Thomas RG; Ferris SH
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S22-32. PubMed ID: 9236949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive function impairment in community elderly subjects with questionable dementia.
    Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):86-90. PubMed ID: 15572877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term progression of Alzheimer's disease in patients under antidementia drugs.
    Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Gardette V; Coley N; Cantet C; Gauthier S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2011 Nov; 7(6):579-92. PubMed ID: 22055975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced semantic fluency as an additional screening tool for subjects with questionable dementia.
    Lam LC; Ho P; Lui VW; Tam CW
    Dement Geriatr Cogn Disord; 2006; 22(2):159-64. PubMed ID: 16837791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.
    Maurano STP; da Silva DJ; Ávila MP; Magacho L
    Int Ophthalmol; 2018 Oct; 38(5):1839-1844. PubMed ID: 28744790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
    Patterson MB; Mack JL; Mackell JA; Thomas R; Tariot P; Weiner M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S40-4. PubMed ID: 9236951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.